<DOC>
	<DOCNO>NCT02051972</DOCNO>
	<brief_summary>The objective study confirm clinical performance safety Nanostim leadless cardiac pacemaker system within intend use accord instruction use .</brief_summary>
	<brief_title>The LEADLESS Observational Study</brief_title>
	<detailed_description />
	<criteria>Subject must one follow clinical indication : Chronic atrial fibrillation 2 3° AV bifascicular bundle branch block ( BBB block ) ; Normal sinus rhythm 2º 3° AV BBB block low level physical activity short expect lifespan ( least one year ) ; Sinus bradycardia infrequent pause unexplained syncope EP finding ; Subject ≥18 year age ; Subject life expectancy least one year suitable candidate base overall health wellbeing ; Subject enrol another clinical investigation treatment arm could confound result study ; Subject willing comply clinical investigation procedure agree return require followup visit , test , exam ; Subject inform nature study , agree provision provide write informed consent , approve EC ; Subject pregnant plan get pregnant course study . Known pacemaker syndrome , retrograde VA conduction suffer drop arterial blood pressure onset ventricular pacing ; Hypersensitivity &lt; 1 mg dexamethasone sodium phosphate ; Mechanical tricuspid valve prosthesis ; Preexisting pulmonary arterial ( PA ) hypertension ( PA systolic pressure exceed 40mmHg RV systolic pressure ( RVSP ) estimate echo exceeds 40mmHg ) significant physiologicallyimpairing lung disease ( severe pulmonary disease produce frequent hospitalization respiratory distress require continuous home oxygen ) ; Preexisting ventricular pace defibrillation lead ; Current implantation either conventional subcutaneous implantable cardioverter defibrillator ( ICD ) cardiac resynchronization therapy ( CRT ) ; Presence implant vena cava filter ; Evidence thrombosis one vein used access procedure ; Cardiovascular peripheral vascular surgery/intervention within 30 day enrolment ; Presence implant leadless cardiac pacemaker</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>